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ABSTRACT 
Microbiota are micro-organisms that colonize the internal and external surfaces of the body and 
contribute to developmental processes and the microbiota-gut-brain axis, thereby to the high 
comorbidity between mental and gastrointestinal diseases. Recent evidence suggests that the gut 
microbiota influence the expression of vasopressin (AVP), a neuropeptide that mediates anxiety, 
stress and sickness behaviors and oxytocin (OXT), a neuropeptide that modulates social behavior 
and energy homeostasis. One way that the gut microbiota can be altered is through diet. Dietary 
emulsifiers, ambiphillic molecules used to stabilize emulsions of oil and water, alter the gut 
microbiome and increase intestinal inflammation. Recently, we have demonstrated that the 
emulsifiers carboxymethylcellulose (CMC) and polysorbate 80 (P80) increase anxiety-like 
behavior and reduce social behavior. Here, we investigate the roles of AVP and OXT as potential 
neural mechanisms by which emulsifiers alter anxiety and social behaviors. To test, male and 
female mice were weaned at 3 weeks of age, started in water (control), CMC or P80 treatment, 
and remained on treatment throughout the duration of the experiment. A standard battery of 
anxiety and social behavior tests was conducted starting at 10 weeks of age. A week following 
the completion of the last behavioral task, mice were euthanized, and brains were harvested and 
processed immunoreactivity (IR) of AVP and OXT in brain areas associated with stress and 
   
 
metabolism, such as the paraventricular nucleus of the hypothalamus (PVN) and paraventricular 
nucleus of the thalamus (PVT). There was no main effect of treatment in AVP-IR in the PVN or 
PVT or OXT-IR in the PVN. There was a main effect of sex in AVP-IR in the PVN. Therefore, 
the results do not support the hypothesis regarding vasopressin and oxytocin expression in the 
PVN and PVT of mice with emulsifier-induced intestinal inflammation. Altered expression of 
AVP and OXT may not be a mechanism by which dietary emulsifiers cause changes in anxiety-
like and social behavior. 
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INTRODUCTION 
 Microbiota are all the micro-organisms that colonize the internal and external surfaces of 
the body (Montiel-Castro et al., 2013). The microbiota species that reside in the intestines or gut 
play critical roles in digestion and absorption of food as well as in development of the immune 
system. In addition, the gut microbiota has been shown to communicate bi-directionally with the 
brain, via the microbiota-gut-brain axis. For example, there is a high comorbidity between 
neurological and gastrointestinal disorders, which may be explained by this communication 
pathway (Foster & Neufeld, 2013).  Furthermore, patients with autism spectrum disorder (ASD) 
show increased frequency of functional GI disorders, which are caused by altered microbiome-
gut-brain signals, specifically in the form of decreased tryptophan levels, increased serotonin 
metabolite levels, and increased cytokine levels correlating with differences in microbiome 
composition between patients with and without ASD (Luna et al., 2016). 
 Disruptions of the microbiota-gut-brain axis lead to significant changes in behavior. Mice 
raised without microbiota, germ free (GF) mice, have an immature immune system, decreased 
hypothalamic-pituitary axis stress response, and decreased anxiety-like behavior (De Palma et 
al., 2014). GF mice also display reduced social behaviors (Desbonnet et al., 2014). In contrast, 
mice with an increase in pro-inflammatory microbiota show increased anxiety-like behaviors 
(Neufeld et al., 2011).  
 Dietary emulsifiers are detergent-like, ambiphillic molecules commonly added in 
processed foods, such as ice cream, mayonnaise, margarine, and peanut butter, that prevent the 
separation of the lipid and aqueous layers. It has been shown that dietary emulsifiers lead to the 
proliferation of the pro-inflammatory microbiota, leading to symptoms of low-grade 
inflammation and metabolic syndrome in mice, such as increased adiposity and dysglycemia 
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(Chassaing et al., 2015). Two commonly found dietary emulsifiers are carboxymethylcellulose 
(CMC) and polysorbate 80 (P80). These two emulsifiers also lead to robust effects in preliminary 
behavior tests, such as in the open field test, elevated plus maze, and three-chambered sociability 
test (Holder et al., 2016).   
 Further research in our lab has found that emulsifier administration increases anxiety-like 
behaviors in both male and female mice and decreases social behaviors in female mice. These 
sexually dimorphic behavior changes were seen with chronic low grade inflammation, increased 
adiposity, and increased drive for feeding induced by dietary emulsifiers (Holder et al., 2016). 
Although these physiological and behavior effects of dietary emulsifiers have been established, it 
is unclear how administration of emulsifiers leads these effects. Perturbations in the gut 
microbiome may induce these effects in several ways, from altered neurotransmitter or 
neuropeptide levels, autonomic nervous system signaling, or changes in components of the 
innate immune system (Li and Zhou, 2016). 
 A potential mechanism by which dietary emulsifiers may induce pathophysiological and 
behavioral changes is via the vasopressin and oxytocin systems of the brain. Vasopressin (AVP), 
or anti-diuretic hormone is expressed in a sexually dimorphic manner in the brain and has 
numerous functions in the body including water and solute balance and stress response via the 
hypothalamic-pituitary-adrenal (HPA) axis. Chronic stress can alter HPA axis activity, inducing 
gut dysbiosis and changing the composition and function of the gut microbiota (Bienenstock et 
al., 2015). Vasopressin is also released during chronic stress and may be a method by which 
changes in the gut microbiome induce changes the brain. Oxytocin is a similar neuropeptide with 
various functions, such as uterine contraction, milk letdown, energy homeostasis, and 
modulation of social behaviors. Both neurohormones are synthesized in and released from cell 
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bodies of neurons located in the paraventricular nucleus of the hypothalamus (PVN), a prominent 
brain area involved in the stress response. Vasopressin neurons in the suprachiasmatic nucleus 
(SCN) project to the paraventricular nucleus of the thalamus (PVT), an essential brain area in the 
HPA axis that integrates multiple neural and humoral inputs to control food intake, energy 
expenditure, and hormone levels (Fodor et al., 2013). Examining the AVP and OXT systems in 
these specific brain areas would be beneficial to determine a possible mechanism of action of 
dietary emulsifiers’ effects on behavior and the body.  
 Therefore, the overall research question is how does administration of two commonly 
used dietary emulsifiers, CMC and P80, influence vasopressin and oxytocin, two neuropeptides 
implemented in anxiety-like and social behavior? We predict that because vasopressin is a 
neuropeptide released during stress and emulsifier-induced intestinal inflammation is a type of 
stressor, vasopressin immunoreactivity in both the PVN and PVT will be increased in mice 
treated with emulsifies. We also predicted that because oxytocin modulates social behaviors and 
social behaviors are decreased during stress and following emulsifier treatment, oxytocin 
immunoreactivity in the PVN will be decreased in mice treated with emulsifiers.  
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METHODS 
Animals 
 C57Bl/6 dams with litters (3 male and 3 female 14-day-old pups) were purchased from 
Charles River Laboratories.   Mice were housed in ventilated transparent OptiMouse plastic 
cages with Bed-O-Cobs® and AlphaDri bedding (35.6 x 48.5 x 21.8cm; at Georgia State 
University).  Room lights were set to a 14h:10h light:dark cycle (lights off at 0900 ET), and 
ambient temperature was maintained at 23°C.  Food (Purina rodent chow no. 5001) and water 
were available ad libitum.  Mice were weaned postnatal day 21 (P21) and put into a new cage 
(randomized to littermates) such that each experimental group contained mice from all litters and 
that each litter was used for all experimental groups.  All procedures were in accordance with the 
Guide for Care and Use of Laboratory Animals and were approved by the Animal Care and Use 
Committee at the Georgia State University. 
Treatments 
 Upon weaning at age P21, male and female mice were transferred to new cages and 
began treatment with water or a 1% concentrated solution of either sodium 
carboxymethylcellulose (CMC) or Polysorbate 80 (P80) in the drinking water, forming six 
different experimental groups of six animals each. Animals were monitored weekly, their body 
weights were recorded, and they remained on treatment throughout the duration of the 
experiment.  
Behavioral Testing 
 After ten weeks on treatment starting at age P70, the animals underwent a standard 
battery of behavior tests for anxiety-like, depression-like, and social behavior. One behavior test 
was conducted each week. A total of six different behavior tests were conducted, including the 
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open field test, elevated plus maze, light/dark box, marble burying test, three-chambered 
sociability test, and forced swim test. 
Tissue Collection 
 One week following the last behavior test, mice were deeply anesthetized under 
isoflurane (5%v/v).  Blood was collected by retrobulbar intraorbital capillary plexus.  Hemolysis-
free serum was generated by centrifugation of blood using serum separator tubes (Becton 
Dickinson, Franklin Lakes, NJ).  Mice were euthanized by cervical dislocation, and the colons, 
spleens, livers, and adipose were collected for subsequent analysis. Brains were removed and 
submersed into a fixative solution of 5% acrolein in sodium phosphate buffer (0.1M, pH 7.4) at 
4°C, followed by cryoprotection in 30% sucrose in phosphate buffered saline (PBS: 0.05M, 
ph7.4). Brains were sectioned (30µm) in the coronal plane in a cryostat and stored in a 
cryoprotectant solution (ethylene glycol/sucrose in sodium phosphate buffer) until 
immunostained. 
Immunohistochemistry 
 Immunohistochemistry (IHC) was conducted to visualize the immunoreactivity (IR) of 
vasopressin (AVP) and oxytocin (OXT). The IHC process utilizes the natural and biological 
function of antibodies binding to antigens to detect the presence of specific antigens, in this case 
AVP and OXT, in brain areas of interest.  
 For the process of AVP immunohistochemistry, brain tissue underwent washes in 0.05 M 
Tris-buffered saline (TBS) to remove all traces of the cryoprotectant, and then were incubated in 
0.05 sodium citrate in TBS at 70°C, cooled, incubated in 0.1 M Glycine in TBS, and then in 
blocking solution containing TBS, 10% normal goat serum (NGS), 0.4% Triton-X, and 1% 
hydrogen peroxide. Each incubation was followed by rinses in TBS solution. Then, the tissue 
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was incubated in rabbit anti-AVP primary antibody (Bachem, T-4563) overnight at a dilution of 
1:46,000 in TTG, a solution containing 94% of 0.05 M TBS, 4% of 10% Triton-X, and 2% of 
NGS. After this incubation, the series of tissue was rinsed in TTG and then incubated in 
Biointylated goat-anti-rabbit IgG secondary antibody (Vector BA-7000) at a dilution of 1:800 in 
TTG. Following rinses in TBS containing 0.4% Triton-X, the tissue was incubated in avidin-
biotin solution (Vector ABC-Elite standard kit) in TBS for 1 hour at room temperature. Next, 
tissue underwent more TBS rinses and washes in sodium acetate solution, followed by a 30-
minute incubation in DAB solution, containing sodium acetate buffer, nickel sulfate, 3, 3, 
diaminobenzidine, and 5% hydrogen peroxide. After visualization, sections were rinsed in 
sodium acetate buffer and TBS, the experimental sections were stored in TBS at 20°C until 
mounting. 
 The process of OXT immunohistochemistry was a two-day protocol similar to that of 
AVP IHC. Differences included no incubation in sodium citrate, and the tissue was incubated in 
guinea pig anti-OXT primary antibody (Peninsula Labs) at a dilution of 1:12,000 in TTG, and 
later in Biotinylated goat-anti guinea pig IgG secondary antibody (Vector BA-7000) at a dilution 
of 1:800 in TTG. Upon completion of the DAB IHC protocol for OXT, sections were stored in 
TBS at 20°C until mounting. 
 All experimental tissue was mounted rostro-caudally onto double-dipped, gelatin coated 
slides. Slides were labeled to ensure unbiased analysis and allowed to dry overnight at room 
temperature. The slides then underwent timed baths of increasing alcohol concentration to 
dehydrate the tissue and then washes in xylene to clear the tissue of residual alcohol and fats. 
They were coverslipped with glass coverslips using permount, allowed to dry overnight, then 
cleaned with 100% ethanol. 
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Threshold Image Analysis 
 The processed sections were imaged with a photomicroscope at anatomically-matched 
positions. Three to four images encompassing the PVN and PVT of the stained tissue were 
captured for each animal. Microscope conditions were standardized to prevent variability 
between images. Examples of these images for the various groups are included in the results 
section. Next, photomicrographs were subjected to gray-level threshold analysis using a 
previously-established algorithm in the Image J software (Murray et al., 2011; Rood et al., 2008). 
The area of AVP or OXT-immunoreactivity (IR) in pixels was recorded for each image and the 
average area was calculated for each subject. 
Statistical Analysis 
 Data are represented as means + SEM or ± SEM where appropriate. The average IR of 
each neuropeptide in each experimental group was determined and statistically analyzed using 
repeated measures 2-way analysis of variance (ANOVA) where treatment and sex were the 
between-subjects variables. Significance for all analyses was set at p < 0.05. 
 
 
 
 
 
 
 
 
 
8 
 
RESULTS 
Vasopressin 
 We hypothesized that administration of emulsifiers will increase AVP-IR in the PVN of 
the brain. The average immunoreactivity area in pixels for each of the six groups was quantified. 
There were no significant main effects of treatment (F(2, 29) = 1.802; P > 0.05) or sex (F(1, 29) 
= 0.4303; P > 0.05). In addition, there was no interaction between sex and treatment (F(2,29) = 
0.06106; P > 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Effects of emulsifiers on vasopressin immunoreactivity in the PVN 
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 We hypothesized that administration of emulsifiers will increase AVP-IR in the PVT of 
the brain. The average immunoreactivity area in pixels for each of the six groups was quantified. 
There were no significant main effects of treatment (F(2, 29) = 0.6942; P > 0.05). There was a 
significant main effect of sex observed (F (1, 29) = 5.429; p = 0.0270), in which females showed 
significantly lower AVP-IR in the PVN compared to males. There was no interaction between 
sex and treatment (F(2,29) = 0.1601; p > 0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2. Effects of emulsifiers on vasopressin immunoreactivity in the PVT 
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Oxytocin 
 We hypothesized that administration of emulsifiers will decrease OXT-IR in the PVN of 
the brain. The average immunoreactivity area in pixels for each of the six groups was quantified. 
There were no significant main effects of treatment (F(2, 29) = 0.8444; p > 0.05) or sex (F(1, 29) 
= 0.08876; p > 0.05). In addition, there was no interaction between sex and treatment (F(2,29) = 
0.6430; p > 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3. Effects of emulsifiers on oxytocin immunoreactivity in the PVN 
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DISCUSSION 
 Our results demonstrated that there were no significant effects of emulsifier treatment on 
the AVP-IR and OXT-IR in the PVN and PVT areas of the mouse brain. Thus, our hypothesis 
that administration of emulsifiers would increase AVP-IR in the PVN and PVT and decrease 
OXT-IR in the PVN was refuted. This was a surprising finding as previously discovered effects 
of emulsifier treatment on anxiety-like and social behavior indicated changes that may be linked 
to alterations in the vasopressin and oxytocin systems of the brain. There are several 
explanations and future directions for these results, including expanding on the various brain 
areas analyzed and analysis using the age and developmental stage of the animals. 
 The PVN and PVT were two brain areas chosen for analysis due to their prominent 
functions in the vasopressin and oxytocin systems and in stress-related and social behavior. The 
lack of significant effects of emulsifier treatment in the PVN and PVT of the mice may indicate 
the need to study other brain areas, such as the amygdala and bed nuclei of the stria terminalis 
(BNST). The central amygdala has been shown to be critical in the processing of anxiety and 
fear responses to stress. AVP is also synthesized in the medial amygdala (Smith et al., 2017) and 
there are well-documented AVP projections to the amygdala from AVP-containing 
magnocellular neurosecretory neurons (Hernández et al., 2016). Both AVP and OXT levels are 
increased in the amygdala in response to stress (Dabrowska et al., 2011). Due to profound 
behavior effects that AVP likely exerts in the amygdala, this area should be investigated as a 
region where emulsifiers may induce changes in AVP. The BNST is another brain area involved 
in the stress response, synthesizes AVP (Smith et al., 2017), and contains one of the highest 
levels of OXT receptor mRNA. There is also anatomical support for the existence of direct 
synaptic pathways linking hypothalamic OXT-IR neurons with the BNST, indicating that this 
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may be another region of action for stress-induced changes in OXT expression (Dabrowska et 
al., 2011). OXT-IR in the PVT was not able to be analyzed due to time constraints, but should 
also be performed to determine differences in this area. Although no significant differences were 
found in the PVN and PVT from this study, other brain areas should be analyzed to determine 
possible region-specific influences of microbiota on AVP and OXT immunoreactivity. 
 Furthermore, the lack of significant effects of emulsifier treatment on AVP-IR and OXT-
IR may be due to the developmental stage of the animals tested. In this experiment, there was 
only one time schedule of treatment and all animals were administered a constant level of 
emulsifiers throughout their entire development. In addition, the effects of dietary emulsifiers 
were only determined at adulthood. It is possible that emulsifiers demonstrate their effects at 
earlier time periods of development, such as neonatally or at juvenile age and that these effects 
are abolished after the onset of puberty or during adulthood. Developmental differences in AVP 
and OXT regulation of social behavior has been shown in that juvenile rats aged P35 
demonstrate increased social behavior compared to their adult counterparts, and AVP and OXT 
receptor binding density was significantly higher in juveniles than in adults in several brain areas 
(Smith et al., 2017). Future studies can test the effects of these emulsifiers across various ages 
through different scheduling of administration from birth through adulthood to pinpoint 
developmental effects of emulsifier-induced intestinal inflammation. 
 Although there were no significant main effects of treatment on AVP-IR and OXT-IR in 
the brain areas studied, there was a significant main effect of sex in the AVP-IR in the PVT, in 
that males had increased AVP-IR than females. This result indicates a basal difference in AVP 
expression in this area, unaffected by emulsifier treatment. Although this sex difference in this 
particular area is a novel finding, AVP has been consistently shown to be sexually dimorphic in 
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the same manner in the BNST, and AVP-IR projections from the BNST to the lateral septum, 
lateral habenular nucleus, and periaqueductal gray was significantly higher in males than in 
females (De Vries and al-Shamma, 1990). In addition, conventionally colonized Swiss Webster 
mice demonstrate a sex difference in AVP-IR in the PVN with males showing increased AVP-IR 
compared to females (Mehta et al., 2015). It would be interesting to see whether OXT-IR 
demonstrates a similar basal sex difference in the PVT. 
 In conclusion, this research did not reveal the vasopressin and oxytocin systems as 
possible molecular mechanism for the effects of emulsifier treatment on physiological and 
behavior changes in mice. Further findings in this field may uncover an underlying neural 
mechanism for neurological and gastrointestinal diseases, leading to possible targets for 
treatment. 
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